# Transactions of Managers and Closely Associated Persons
Canonical URL: https://biopharmsignal.com/news/ALVO/transactions-of-managers-and-closely-associated-persons-9140a9e4
Ticker: ALVO
Company: Alvotech
Source: Alvotech
Published: 2026-07-03 20:01 EST
## Summary

Attached are copies of two filings with the Luxembourg Commission de Surveillance du Secteur Financier (CSSF) regarding transactions of managers and...

## Article Body
Attached are copies of two filings with the Luxembourg Commission de Surveillance du Secteur Financier (CSSF) regarding transactions of managers and closely associated persons, announcing the pledging of (i) 88,940,619 shares and (ii) 7,007,321 depository receipts on shares in Alvotech by Celtic Lux Holdings S.a. r.l. (formerly known as Alvogen Lux Holdings S.a. r.l.). The date of the transactions was June 26, 2026.

Alvotech Investor Relations Benedikt Stefansson, VP alvotech.ir@alvotech.com

Managers Transactions - CSSF Form - Celtic Lux Holdings S.à r.l. 2026-07-02 (i)

Managers Transactions - CSSF Form - Celtic Lux Holdings S.à r.l. 2026-07-02 (ii)
## Recent Company News
- 2026-07-03 20:01 EST — [Viðskipti stjórnenda og tengdra aðila](https://biopharmsignal.com/news/ALVO/vi-skipti-stj-rnenda-og-tengdra-a-ila-53408632) — Source: Alvotech
- 2026-07-03 20:01 EST — [Transactions of Managers and Closely Associated Persons](https://biopharmsignal.com/news/ALVO/transactions-of-managers-and-closely-associated-persons-9140a9e4) — Source: Alvotech
- 2026-07-01 08:00 EST — [Alvotech styrkir lausafjárstöðu sína enn frekar með aðgengi að 75 milljóna dala lánsfjármögnun](https://biopharmsignal.com/news/ALVO/alvotech-styrkir-lausafj-rst-u-s-na-enn-frekar-me-a-gengi-a-75-millj-na-dala-l-n-5c600a72) — Source: Alvotech
- 2026-07-01 08:00 EST — [Alvotech further strengthens liquidity by securing term loan facility of $75 million](https://biopharmsignal.com/news/ALVO/alvotech-further-strengthens-liquidity-by-securing-term-loan-facility-of-75-mill-80932cf9) — Source: Alvotech
- 2026-06-22 22:48 EST — [Viðskipti stjórnenda og tengdra aðila](https://biopharmsignal.com/news/ALVO/vi-skipti-stj-rnenda-og-tengdra-a-ila-28f847d7) — Source: Alvotech
## Related News
- 2026-07-28 13:00 EST — ENLV — [Enlivex Announces $400,000,000 Private Placement](https://biopharmsignal.com/news/ENLV/enlivex-announces-400-000-000-private-placement-20e71a7a)
- 2026-07-28 12:30 EST — XRAY — [Dentsply Sirona Advances Commercial Growth Strategy in Canada Through Expanded Medline Sinclair Relationship](https://biopharmsignal.com/news/XRAY/dentsply-sirona-advances-commercial-growth-strategy-in-canada-through-expanded-m-e2440bb2)
- 2026-07-28 12:30 EST — RLMD — [Relmada Therapeutics Appoints Uro-Oncology Leader Bipin Dalmia as Chief Business Officer](https://biopharmsignal.com/news/RLMD/relmada-therapeutics-appoints-uro-oncology-leader-bipin-dalmia-as-chief-business-5c4d7b11)
- 2026-07-28 12:05 EST — RIGL — [Rigel Announces Conference Call and Webcast to Report Second Quarter 2026 Financial Results](https://biopharmsignal.com/news/RIGL/rigel-announces-conference-call-and-webcast-to-report-second-quarter-2026-financ-5b987d7a)
- 2026-07-28 12:05 EST — GSK — [GSK to establish new flagship R&D centre on Cambridge Biomedical Campus, UK](https://biopharmsignal.com/news/GSK/gsk-to-establish-new-flagship-r-d-centre-on-cambridge-biomedical-campus-uk-6f2bb859)